171 related articles for article (PubMed ID: 9466478)
1. Molecular pathogenesis and targets for therapy in myelodysplastic syndrome (MDS) and MDS-related leukemias.
Karp JE
Curr Opin Oncol; 1998 Jan; 10(1):3-9. PubMed ID: 9466478
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of MDS.
Hirai H
Int J Hematol; 2002 Aug; 76 Suppl 2():213-21. PubMed ID: 12430928
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of myelodysplastic syndrome.
Hirai H
Jpn J Clin Oncol; 2003 Apr; 33(4):153-60. PubMed ID: 12810828
[TBL] [Abstract][Full Text] [Related]
4. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
5. Understanding the pathogenesis of myelodysplastic syndromes.
Delforge M
Hematol J; 2003; 4(5):303-9. PubMed ID: 14502253
[TBL] [Abstract][Full Text] [Related]
6. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
7. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
[TBL] [Abstract][Full Text] [Related]
8. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
[TBL] [Abstract][Full Text] [Related]
9. [Myelodysplastic syndromes--an overview for the practitioner].
Solenthaler M; Tobler A
Ther Umsch; 2004 Feb; 61(2):117-24. PubMed ID: 15018394
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic analysis of de novo acute myeloid leukemia with trilineage myelodysplasia in comparison with myelodysplastic syndrome evolving to acute myeloid leukemia.
Tamura S; Takemoto Y; Hashimoto-Tamaoki T; Mimura K; Sugahara Y; Senoh J; Furuyama JI; Kakishita E
Int J Oncol; 1998 Jun; 12(6):1259-62. PubMed ID: 9592183
[TBL] [Abstract][Full Text] [Related]
11. Biology of the bone marrow microenvironment and myelodysplastic syndromes.
Rankin EB; Narla A; Park JK; Lin S; Sakamoto KM
Mol Genet Metab; 2015; 116(1-2):24-8. PubMed ID: 26210353
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy- and chemotherapy-induced myelodysplasia and acute myeloid leukemia. A review.
Pedersen-Bjergaard J
Leuk Res; 1992; 16(1):61-5. PubMed ID: 1732675
[TBL] [Abstract][Full Text] [Related]
13. Thrombocytemia and abnormal megakaryopoiesis associated with abnormality of chromosome 1p34 in myelodysplastic syndromes.
Jondeau K; Bouscary D; Viguié F; Picard F; Melle J; Lopez I; Fontenay-Roupie M; Dreyfus F
Leukemia; 1996 Nov; 10(11):1692-5. PubMed ID: 8892668
[TBL] [Abstract][Full Text] [Related]
14. Myelodysplastic syndromes: the pediatric point of view.
Locatelli F; Zecca M; Pession A; Maserati E; De Stefano P; Severi F
Haematologica; 1995; 80(3):268-79. PubMed ID: 7672722
[TBL] [Abstract][Full Text] [Related]
15. Therapy-related myelodysplastic syndrome.
Candelaria M; Dueñas-Gonzalez A
Expert Opin Drug Saf; 2015 May; 14(5):655-65. PubMed ID: 25675961
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic features of myelodysplastic syndromes (MDS).
Willman CL
Leukemia; 1998 Sep; 12 Suppl 1():S2-6. PubMed ID: 9777886
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndrome in children: differentiation from acute myeloid leukemia with a low blast count.
Chan GC; Wang WC; Raimondi SC; Behm FG; Krance RA; Chen G; Freiberg A; Ingram L; Butler D; Head DR
Leukemia; 1997 Feb; 11(2):206-11. PubMed ID: 9009082
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.
Kurotaki H; Tsushima Y; Nagai K; Yagihashi S
Acta Haematol; 2000; 102(3):115-23. PubMed ID: 10692673
[TBL] [Abstract][Full Text] [Related]
19. Prediction of therapy-related acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) after autologous bone marrow transplant (ABMT) for lymphoma.
Legare RD; Gribben JG; Maragh M; Hermanowski-Vosatka A; Roach S; Tantravahi R; Nadler LM; Gilliland DG
Am J Hematol; 1997 Sep; 56(1):45-51. PubMed ID: 9298868
[TBL] [Abstract][Full Text] [Related]
20. Analysis of CHK2 in patients with myelodysplastic syndromes.
Aktas D; Arno MJ; Rassool F; Mufti GJ
Leuk Res; 2002 Nov; 26(11):985-7. PubMed ID: 12363465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
